CancerIQ Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 44

Employees
  • Latest Deal Type

  • Series B

  • Latest Deal Amount

  • $14M

  • Investors

  • 23

CancerIQ General Information

Description

Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer. The company's platform offers predictive analytics and screening tools to identify at-risk patients, clinical guidance with proven outcomes, a digital genetic test ordering platform, and patient management and education tools, enabling clinicians to save time, reduce the cost of care, and improve outcomes by detecting cancer at an early stage.

Contact Information

Website
www.canceriq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Biotechnology
Primary Office
  • 515 North State Street
  • Suite 1025
  • Chicago, IL 60654
  • United States
+1 (312) 000-0000

CancerIQ Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CancerIQ Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 03-Mar-2022 $14M 000.00 0000 Completed Generating Revenue
8. Later Stage VC 23-Mar-2021 000 000.00 Completed Generating Revenue
7. Debt - PPP 29-Apr-2020 00000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A2) 23-Apr-2020 00.00 000.00 0000 Completed Generating Revenue
5. Later Stage VC (Series A) 19-Nov-2018 00.00 00.00 000.00 Completed Startup
4. Seed Round 12-Aug-2016 000 00.00 000 Completed Startup
3. Accelerator/Incubator 28-Oct-2014 00000 Completed Startup
2. Accelerator/Incubator 09-Apr-2014 $100K Completed Startup
1. Accelerator/Incubator 05-Jun-2013 $100K $100K Completed Startup
To view CancerIQ’s complete valuation and funding history, request access »

CancerIQ Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B2 0,000,000 00.000000 00.0 00.0 00 00.0 000
Series B 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 2,907,298 $0.000100 $1.23 $1.23 1x $1.23 8.12%
Seed 4,003,578 $0.000100 $0.66 $0.66 1x $0.66 11.18%
To view CancerIQ’s complete cap table history, request access »

CancerIQ Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer.
Decision/Risk Analysis
Chicago, IL
44 As of 2023
000.00
000 0000-00-00
00000000000 000.00

00000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nis
0000000000000 000000
Pittsburgh, PA
00 As of 0000
00.00
0000000000 0 00.00

000 00

lor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla paria
0000000000000 000000
Waltham, MA
00 As of 0000
000
000 0000-00-00
000000&0 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CancerIQ Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ariel Precision Medicine Venture Capital-Backed Pittsburgh, PA 00 00.00 0000000000 0 00.00
000 000000 Formerly VC-backed Waltham, MA 00 000 000000&0 000
00000 000000 Venture Capital-Backed Lexington, KY 00 00.00 0000000000 0 00.00
You’re viewing 3 of 3 competitors. Get the full list »

CancerIQ Executive Team (9)

Name Title Board Seat Contact Info
Olufeyikemi Ayodele Co-Founder, Chief Executive Officer & Board Member
Laku Adedoyin Chief Technology Officer
Olufunmilayo Olopade MD Co-Founder, Co-Chief Scientific Officer & Board Member
Haibo Lu Co-Founder & Chief Data Officer
You’re viewing 4 of 9 executive team members. Get the full list »

CancerIQ Board Members (9)

Name Representing Role Since
Andrea Metkus CancerIQ Board Member 000 0000
Carladenise Edwards Ph.D Self Board Member 000 0000
Joel Krikston Merck Global Health Innovation Fund Board Member 000 0000
Mark Bakken HealthX Ventures Board Member 000 0000
Olufeyikemi Ayodele CancerIQ Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

CancerIQ Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CancerIQ Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
HealthX Ventures Venture Capital Minority 000 0000 000000 0
McKesson Ventures Corporate Venture Capital Minority 000 0000 000000 0
Merck Global Health Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
OSF Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial